DEF 14A: Singularity Future Tech Seeks Equity Issuance Approval

Sentiment:

Special Meeting Proxy Statement


Singularity Future Technology Ltd. calls a special meeting on November 7, 2025, for stockholders to approve three significant equity and warrant issuances, including a class action settlement.

Capital raiseThe company is seeking approval for the issuance of 1,700,000 warrants at an exercise price of $6.07 per share, originating from a subscription agreement with non-affiliated investors.The company is seeking approval for the issuance of 32,188,841 units, each consisting of one common share and three warrants, in a private placement to non-U.S. persons for an aggregate price of US$30 million.

Summary

  • A Special Meeting of Stockholders is scheduled for November 7, 2025, at 11 p.m. Hong Kong time, to vote on three key proposals.
  • Stockholders of record as of October 21, 2025, are eligible to vote at the Special Meeting.
  • Proposal One seeks approval for the issuance of 1,700,000 warrants, each exercisable to purchase one share of common stock at $6.07 per share, as adjusted from a November 15, 2023 subscription agreement.
  • Proposal Two requests approval for the issuance of 32,188,841 units, each unit comprising one common stock share and three warrants (2025 Warrants), with each 2025 Warrant exercisable at $1.165 per share, from a June 19, 2025 private placement to non-U.S. persons for an aggregate price of US$30 million.
  • Proposal Three asks for approval to issue up to 6,500,000 unrestricted common shares as part of a settlement in the class action lawsuit Crivellaro v. Singularity Future Technology Ltd., with a value not less than $5,850,000.
  • The Board of Directors unanimously recommends a vote FOR all three proposals.
  • As of the record date, 7,293,492 shares of Common Stock were issued and outstanding.

Sentiment

Score: 3

Explanation: While the resolution of a class action lawsuit is a positive, the overall sentiment is negative due to the substantial potential dilution from multiple equity and warrant issuances. The large number of units and settlement shares, coupled with the significantly lower exercise price of the 2025 warrants compared to earlier ones, suggests a considerable impact on existing shareholder value and potential downward pressure on the stock price. The capital raise is necessary but comes at a high cost to current shareholders.

Positives

  • The proposed settlement of the class action lawsuit (Crivellaro v. Singularity Future Technology Ltd.) could resolve significant legal uncertainty and remove a potential financial overhang.
  • The private placement of units, raising US$30 million, provides capital for working capital and general corporate purposes.

Negatives

  • The issuance of 1,700,000 warrants, 32,188,841 common shares, 96,566,523 (32,188,841 * 3) 2025 warrants, and 6,500,000 settlement shares represents significant potential dilution to existing stockholders.
  • The issuance of settlement shares will dilute the percentage ownership interest of all stockholders, may dilute the book value per share, and could depress the market price of common stock.
  • The issuance of settlement shares could have an anti-takeover effect by diluting the voting power of a person seeking control.
  • The exercise price of the 2025 Warrants ($1.165) is substantially lower than the $6.07 exercise price of the earlier warrants, potentially indicating a lower valuation of the company's stock at the time of the 2025 agreement.

Risks

  • Significant dilution of existing stockholders' ownership percentage, book value per share, and potential depression of the market price of common stock due to the substantial increase in outstanding shares and warrants.
  • The issuance of settlement shares could have an anti-takeover effect by diluting the voting power of a person seeking control of the company.
  • Failure to obtain stockholder approval for any of the proposals could prevent the company from completing the capital raise or the class action settlement, potentially leading to adverse financial or legal consequences.
  • The company is involved in ongoing legal proceedings, specifically the Crivellaro v. Singularity Future Technology Ltd. class action, where a motion to dismiss was partially denied, indicating continued litigation risk until the settlement is finalized and approved by the Court.
  • Compliance with Nasdaq Listing Rule 5635(d) requires stockholder approval for these transactions, and non-approval could lead to compliance issues with the exchange.

Future Outlook

The company intends to announce preliminary voting results at the Special Meeting and will disclose final voting results in a Current Report on Form 8-K filed with the SEC within four business days following the meeting. The company covenants to timely file all required reports with the SEC and will not terminate its status as an issuer required to file reports under the Exchange Act. Net proceeds from the sale of units will be used for working capital and general corporate purposes.

Management Comments

  • The Board recommends that stockholders vote FOR the approval of the Issuance of Warrants, FOR the approval of the Issuance of Units, and FOR the approval of the Issuance of Settlement Shares.

Industry Context

NA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Shareholder Approval RequirementNasdaq Listing Rule 5635(d) mandates stockholder approval for transactions involving the sale or issuance of common stock (or convertible securities) equal to 20% or more of the outstanding common stock or voting power at a price less than the lower of the closing price or five-day average closing price, which applies to the proposed issuances.NAThis ensures compliance with exchange rules and provides existing shareholders with a voice in significant equity-altering transactions, protecting their interests against excessive dilution without their consent.

Legal Proceedings

  • Class action lawsuit: Crivellaro v. Singularity Future Technology Ltd., 1:22-cv-07499-BMC, filed December 9, 2022, alleging violations of federal securities laws related to false or misleading disclosures.
  • On December 17, 2024, the Court partially denied motions to dismiss filed by the Company and its former CEO, Yang Jie, regarding statements about two allegedly fraudulent transactions.
  • A binding term sheet for a class-wide settlement was executed on May 29, 2025, involving the issuance of up to 6,500,000 unrestricted common shares and a put option for unsold shares at $0.85 per share, subject to final Court approval.

Stakeholder Impact

  • Shareholders: Will experience significant dilution of their ownership percentage, book value per share, and potential depression of the market price due to the substantial issuance of new shares and warrants. Their voting power could also be diluted.
  • Plaintiffs in the Class Action: Will receive up to 6,500,000 unrestricted common shares and a put option as part of the settlement, in exchange for releasing all claims against the company and other defendants.
  • Investors in Warrants and Units: Will acquire rights to future equity ownership and potential returns through the warrants and units, providing them with an investment opportunity in the company.

Next Steps

  • Stockholders are encouraged to submit their proxy votes for the Special Meeting on November 7, 2025.
  • The company will announce preliminary voting results at the Special Meeting.
  • Final voting results will be disclosed in a Current Report on Form 8-K filed with the SEC within four business days following the Special Meeting.
  • Upon stockholder approval and satisfaction of other conditions, the company will proceed with the issuance of the 1,700,000 warrants, 32,188,841 units, and up to 6,500,000 settlement shares.
  • The class action settlement requires final approval by the Court.

Key Dates

DateDescription
2022-12-09Piero Crivellaro filed a putative class action lawsuit against the Company.
2023-11-15Company entered into a subscription agreement for 17,000,000 shares and 17,000,000 warrants.
2024-01-26Company entered into an Amendment to Subscription Agreement, requiring Nasdaq authorization and stockholder approval for warrants.
2024-02-12One-for-ten (1-10) reverse stock split of common stock became market effective.
2024-09-30End of period for Form 10-Q referenced in the Securities Purchase Agreement.
2024-11-14Date for capitalization details as set forth in the Company's Form 10-Q.
2024-12-17Court partially denied motions to dismiss filed by the Company and its former CEO in the class action.
2025-01-02Company filed an answer to the Second Amended Class Action complaint.
2025-05-29Company and lead plaintiffs executed a binding term sheet for the class action settlement.
2025-06-19Company entered into a securities purchase agreement for 32,188,841 units.
2025-10-14Company filed its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, with the SEC.
2025-10-21Record date for stockholders entitled to notice of and to vote at the Special Meeting.
2025-10-21Date of Chief Executive Officer Jia Yang's signature on the proxy statement.
2025-10-22Stockholder list will be available at corporate offices for examination.
2025-10-24Proxy statement and accompanying proxy card are being sent to all stockholders entitled to vote.
2025-11-07Date of the Special Meeting of Stockholders.
2030-XX-XXTermination Date for 2025 Warrants (5 years from Issuance Date, which is not specified but is after June 19, 2025).

Recommendation

sell

The filing details proposals for substantial equity and warrant issuances, including 32,188,841 units (each with one common share and three warrants) for $30 million and up to 6,500,000 shares for a class action settlement. This represents significant potential dilution to existing shareholders, which is highly likely to depress the market price and dilute book value per share. While settling a class action lawsuit is a positive step to remove legal overhang, the terms of the capital raise and settlement are highly dilutive, making the stock less attractive for current holders and suggesting a 'sell' recommendation for seasoned investors concerned about shareholder value.

Keywords

Singularity Future Technology, SGLY, SEC filing, DEF 14A, proxy statement, special meeting, shareholder vote, equity issuance, warrants, common stock, private placement, class action settlement, dilution, corporate governance, capital raise, NASDAQ

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.